Andreas Ja Bremers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andreas Ja Bremers has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Albert J. Ten Tije
Department of Medical Oncology, Amphia Ziekenhuis, Langendijk 175, 4819 EV Breda, The Netherlands
1 shared publication - Annemieke Cats
Department of Gastrointestinal Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands
1 shared publication - Apollo Pronk
Diakonessenhuis, Bosboomstraat 1, 3582 KE Utrecht, The Netherlands
1 shared publication B. M. van der Kolk
Department of Surgery, Division of Abdominal and Oncological Surgery, Radboud University Nijmegen Medical Centre , PO Box 9101, 6500 HB Nijmegen
1 shared publication- Christiaan Hoff
Department of Surgery, Medisch Centrum Leewarden, Leeuwarden, The Netherlands
1 shared publication - Cornelis J. A. Punt
Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
1 shared publication
Latest Publications
- 4 February 2013
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 100 (4) , 568-571
Transanal endoscopic microsurgery approach for rectal stump resection as an alternative to transperitoneal stump resection
Background: Transperitoneal rectal stump resection is a complicated procedure with risk of inadvertent bowel, vascular and nerve injury. This study analysed the feasibility and safety of the use of transanal endoscopic microsurgery (TEM) to excise rectal stumps that would otherwise require a combined transabdominal and perineal approach. Methods: Rectal stump resection was performed by a transanal approach using TEM. Stumps were removed by complete rectal wall resection and intersphincteric resection of the anus, leaving the mesorectum in place. Results: The study included nine patients with a rectal stump ranging in length from 8 to 20 cm after previous surgery for inflammatory bowel disease (6), Lynch syndrome (1), collagenous colitis (1) or anastomotic leakage (1). The median duration of operation was 161 (range 107–239) min. The median postoperative length of hospital stay was 5 (range 2–71) days. One patient required an additional small-incision laparotomy to remove a stump extending up to the promontory and another developed a postoperative abscess. There were no perioperative complications. Conclusion: TEM appeared to be a useful and safe approach for close rectal dissection and removal of a rectal stump while avoiding an abdominal approach for pelvic dissection.
- 4 February 2013
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 100 (4) , 568-571
Transanal endoscopic microsurgery approach for rectal stump resection as an alternative to transperitoneal stump resection
Background: Transperitoneal rectal stump resection is a complicated procedure with risk of inadvertent bowel, vascular and nerve injury. This study analysed the feasibility and safety of the use of transanal endoscopic microsurgery (TEM) to excise rectal stumps that would otherwise require a combined transabdominal and perineal approach. Methods: Rectal stump resection was performed by a transanal approach using TEM. Stumps were removed by complete rectal wall resection and intersphincteric resection of the anus, leaving the mesorectum in place. Results: The study included nine patients with a rectal stump ranging in length from 8 to 20 cm after previous surgery for inflammatory bowel disease (6), Lynch syndrome (1), collagenous colitis (1) or anastomotic leakage (1). The median duration of operation was 161 (range 107–239) min. The median postoperative length of hospital stay was 5 (range 2–71) days. One patient required an additional small-incision laparotomy to remove a stump extending up to the promontory and another developed a postoperative abscess. There were no perioperative complications. Conclusion: TEM appeared to be a useful and safe approach for close rectal dissection and removal of a rectal stump while avoiding an abdominal approach for pelvic dissection.
- Open Access
- 15 December 2011
- Published by Springer Nature in BMC Surgery
- Vol. 11 (1) , 34
The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery
The CARTS study is a multicenter feasibility study, investigating the role of rectum saving surgery for distal rectal cancer. Patients with a clinical T1-3 N0 M0 rectal adenocarcinoma below 10 cm from the anal verge will receive neoadjuvant chemoradiation therapy (25 fractions of 2 Gy with concurrent capecitabine). Transanal Endoscopic Microsurgery (TEM) will be performed 8 - 10 weeks after the end of the preoperative treatment depending on the clinical response. Primary objective is to determine the number of patients with a (near) complete pathological response after chemoradiation therapy and TEM. Secondary objectives are the local recurrence rate and quality of life after this combined therapeutic modality. A three-step analysis will be performed after 20, 33 and 55 patients to ensure the feasibility of this treatment protocol. The CARTS-study is one of the first prospective multicentre trials to investigate the role of a rectum saving treatment modality using chemoradiation therapy and local excision. The CARTS study is registered at clinicaltrials.gov ( NCT01273051 )
- 15 December 2011
- Published by Springer Nature in BMC Surgery
- Vol. 11 (1) , 34
Open AccessThe CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery
The CARTS study is a multicenter feasibility study, investigating the role of rectum saving surgery for distal rectal cancer. Patients with a clinical T1-3 N0 M0 rectal adenocarcinoma below 10 cm from the anal verge will receive neoadjuvant chemoradiation therapy (25 fractions of 2 Gy with concurrent capecitabine). Transanal Endoscopic Microsurgery (TEM) will be performed 8 - 10 weeks after the end of the preoperative treatment depending on the clinical response. Primary objective is to determine the number of patients with a (near) complete pathological response after chemoradiation therapy and TEM. Secondary objectives are the local recurrence rate and quality of life after this combined therapeutic modality. A three-step analysis will be performed after 20, 33 and 55 patients to ensure the feasibility of this treatment protocol. The CARTS-study is one of the first prospective multicentre trials to investigate the role of a rectum saving treatment modality using chemoradiation therapy and local excision. The CARTS study is registered at clinicaltrials.gov ( NCT01273051 )
- 31 August 2007
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 33 (6) , 752-756
Prudent application of radiofrequency ablation in resectable colorectal liver metastasis
- 31 August 2007
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 33 (6) , 752-756
Prudent application of radiofrequency ablation in resectable colorectal liver metastasis